SMARCC1 and neoplasm: These analyses showed that 12 TFs were differentially expressed between the MSS and MSI tumour subgroups, that a high transcript level of one TF (SOX4) was significantly associated with poor outcome of stage II MSS cancer and that high protein levels of CBFB and SMARCC1 were correlated with increased overall survival of CRC.